| Unique ID issued by UMIN | UMIN000061084 |
|---|---|
| Receipt number | R000069888 |
| Scientific Title | The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms: single blinded study |
| Date of disclosure of the study information | 2026/03/27 |
| Last modified on | 2026/03/27 15:04:15 |
The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms
RA study
The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms: single blinded study
The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms
| Japan |
Healthy adult
| Adult |
Others
NO
Effects of continued use of the test articles on skin with mild atopic dermatitis symptoms
Efficacy
POEM, VAS
Both before the start and 4 weeks later
Subjective Assessment
4 weeks later
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
No treatment
2
Treatment
| Other |
The test articles were used for 4 weeks on only one side of the face and one side of the arm (three articles on the face-soap, lotion, and serum-and only the serum on the arm)
Leave the other side of the face and the other side of the arm untreated
| 20 | years-old | <= |
| 59 | years-old | >= |
Male and Female
1.Subjects diagnosed with atopic dermatitis or with a history of the condition
2.Subjects with a POEM score of 5-9 for the face and arms
3.Subjects whose symptoms have remained relatively stable over the past month and who have not started any new treatments or changed their current treatment regimen
1.Individuals with excessive exudate, or those with extensive severe inflammation, bleeding, or excoriations
2.Individuals who have regularly used topical steroids, topical immunomodulators, or tacrolimus ointment within the past 2 weeks; individuals who have used oral steroids or immunosuppressants within the past 4 weeks; or individuals who have used biologics within the past 6 months
3.Individuals with skin conditions other than contact dermatitis, psoriasis, or atopic dermatitis on the study sites
4.Individuals who have undergone cosmetic medical procedures on the study sites
5.Pregnant or breastfeeding women, or women planning to become pregnant
6.Individuals undergoing hormone replacement therapy
7.Individuals with severe liver or kidney disease
8.Individuals who have undergone phototherapy within the past month
9.Individuals with an allergy to any component of the test product
10.Individuals who have participated in a human clinical trial within the past month, or who plan to do so during the study period
8
| 1st name | Takeshi |
| Middle name | |
| Last name | Kaneko |
Japan Clinical Trial Association
N.A.
1600022
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
0364574666
info@yakujihou.org
| 1st name | Takeshi |
| Middle name | |
| Last name | Kaneko |
Japan Clinical Trial Association
N.A.
1600022
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
0364574666
info@yakujihou.org
Japan Clinical Trial Association
RISOU Co., Ltd
Profit organization
C-TECJAPAN Co., Ltd.
Institutional Review Board of Pharmaceutical Law Wisdoms
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
0364574911
m
NO
| 2026 | Year | 03 | Month | 27 | Day |
Unpublished
Preinitiation
| 2026 | Year | 02 | Month | 10 | Day |
| 2026 | Year | 02 | Month | 26 | Day |
| 2026 | Year | 03 | Month | 27 | Day |
| 2026 | Year | 04 | Month | 24 | Day |
| 2026 | Year | 03 | Month | 27 | Day |
| 2026 | Year | 03 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069888